daptomycin
Generic: daptomycin
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
daptomycin
Generic Name
daptomycin
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
daptomycin 500 mg/10mL
Manufacturer
Identifiers & Regulatory
Product NDC
63323-371
Product ID
63323-371_7b38aacb-d9c9-47db-a6fe-7e7d938fcd69
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA206077
Listing Expiration
2026-12-31
Marketing Start
2018-04-11
Pharmacologic Class
Established (EPC)
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
63323371
Hyphenated Format
63323-371
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
daptomycin (source: ndc)
Generic Name
daptomycin (source: ndc)
Application Number
ANDA206077 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 500 mg/10mL
Packaging
- 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-371-10) / 10 mL in 1 VIAL, SINGLE-DOSE
Packages (1)
Ingredients (1)
Linked Drug Pages (2)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "7b38aacb-d9c9-47db-a6fe-7e7d938fcd69", "openfda": {"nui": ["N0000175509", "M0519359"], "upc": ["0363323371104"], "unii": ["NWQ5N31VKK"], "rxcui": ["403920"], "spl_set_id": ["a990141d-7b92-48a5-a41d-1254522e2aa1"], "pharm_class_cs": ["Lipopeptides [CS]"], "pharm_class_epc": ["Lipopeptide Antibacterial [EPC]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (63323-371-10) / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "63323-371-10", "marketing_start_date": "20180411"}], "brand_name": "Daptomycin", "product_id": "63323-371_7b38aacb-d9c9-47db-a6fe-7e7d938fcd69", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Lipopeptide Antibacterial [EPC]", "Lipopeptides [CS]"], "product_ndc": "63323-371", "generic_name": "Daptomycin", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Daptomycin", "active_ingredients": [{"name": "DAPTOMYCIN", "strength": "500 mg/10mL"}], "application_number": "ANDA206077", "marketing_category": "ANDA", "marketing_start_date": "20180411", "listing_expiration_date": "20261231"}